Russells Hall Hospital
Dudley, West Midlands, DY1 2HQ, United Kingdom
NCT Number: NCT03740412
The aim of this study is to investigate the feasibility of an intervention to reduce sedentary behaviour in older adults waiting for hip and knee replacements. The study will be a randomised controlled trial design, including 2:1 randomisation into an intervention and usual care group respectively. A target of n=45 patients ≥60 years will be recruited from Russells Hall Hospital, Dudley, UK, approximately 8-10 weeks before surgery, assisted by research nurses. The variable-length intervention, informed by Self-Determination Theory (SDT), will be composed of multiple behaviour change techniques, namely motivational interviewing, individualised feedback on sedentariness, goal-setting, environmental modification, self-monitoring, and social support. Assessments will occur at baseline, 1 week pre-surgery, and 6 weeks post-surgery. The primary outcome will be the feasibility of the trial, assessed quantitatively using study statistics, and with mixed-methods assessment of acceptability, practicality, adaption, satisfaction, and safety via questionnaires given to participants. Exploratory outcomes will include physical function, cardiometabolic biomarkers, measurement of SDT constructs, and both objective and subjective measurement daily activity and sedentariness. The study will last up to 18 weeks per participant.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Dudley, West Midlands, DY1 2HQ, United Kingdom
The aim of this study is to investigate the feasibility of an intervention to reduce sedentary behaviour in n=45 older adults undergoing orthopaedic surgery, at Russells Hall Hospital, Dudley, Birmingham, UK. Recruitment will be via screening of surgery lists followed by direct contact with potentially eligible participants. The intervention is designed utilising Self Determination Theory. It is designed to have multiple components: incorporating individualised feedback on sitting time, education about sedentary behaviour, individualised goal-setting and environmental modification according to each participant's own behavioural patterns and capabilities, motivational interviewing, and biweekly phone calls.
Due to variation in surgery times, the intervention will be variable but can last up to 18 weeks. Each participant will undertake 3-5 visits depending on whether they are in the control group (n=3 visits) or intervention group (n=5 visits). The intervention group will undergo baseline assessments, two intervention meetings, pre-surgical assessments, and a 6-week post-surgical follow up. These visits will occur in different weeks for each participant due to the variability of surgery, however visit 2 will occur 1 week after visit 1. Visit 3 will occur shortly thereafter but may also be combined with visit 2. Visit 4 will occur the week prior to surgery, which is intended to be 6-10 weeks after baseline. Visit 5 occurs 6 weeks post-surgery, which should be 12-18 weeks post-baseline. The primary outcome measure will be feasibility, assessed quantitatively with study statistics. Secondary outcome will be mixed-methods assessment of feasibility via bespoke participant questionnaires. Exploratory outcomes will cover a number of mental and physical health variables, including blood measures to assess cardiometabolic biomarkers, as well as physical function using the short physical performance battery (SPPB). Surgical recovery will be assessed using the Oxford Hip/Knee score and the SPPB. The results of this feasibility study will serve to aid the design of a definitive trial of an intervention to reduce sedentary behaviour in this population.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention has multiple components in order to reduce sedentary behaviour, namely: incorporating individualised feedback on sitting time, education about sedentary behaviour, individualised goal-setting and environmental modification according to each participant's own behavioural patterns and capabilities, motivational interviewing, and biweekly phone calls.
Time frame: Assessed post-study-endpoint (up to month 18)
Study uptake rates (as % of those approached who are randomised, recruitment rates (N/mth)
Time frame: Assessed post-study-endpoint (up to month 18)
Self-recording by participants of goal achievement on a scale of 1-5, recorded each week for the first 6 weeks of the intervention in their goal-setting booklet.
Time frame: Assessed post-study-endpoint (up to month 18)
Percentage of participants whose surgery is scheduled up to 2 weeks prior to the end of the intervention
Time frame: Assessed post-study-endpoint (up to month 18)
Percentage of participants whose surgery is scheduled up to three weeks after the end of the intervention
Time frame: Assessed post-study-endpoint (up to month 18)
Percentage of participants whose surgery is delayed beyond 3 weeks post-intervention
Time frame: Assessed post-study-endpoint (up to month 18)
Assessed by the number of participants who attend the follow-up visit (visit 5, 6 weeks post-surgery)
Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed by custom-made feasibility questionnaire which uses a number of closed and open questions. Closed questions include (Likert 1-5 scale):
How easy was it to achieve your goals physically? How easy was it to achieve your goals mentally? Have you found taking part in the study burdensome?
Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed by custom-made feasibility questionnaires, using both closed and open questions. Closed questions include (1-5 Likert scale):
Could you have changed your goals to make them more achievable? Which part(s) of the intervention did you find most difficult?
Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Whether patients are satisfied, as assessed by feasibility questionnaires given at visit 4 (week prior to surgery) and visit 5 (week post-surgery). This included open and closed questions. Closed questions include (Likert scale 1-5):
Which part(s) of the intervention did you find most enjoyable? How would you rate your overall satisfaction with the study? How likely would you be to suggest taking part in such a study to friends or family? How likely are you to continue working towards your goals in the future?
Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Any change in patient safety as assessed by custom-made feasibility questionnaires. This includes closed and open questions. Closed questions include (Likert 1-3 scale):
Do you feel that taking part in the study has exposed you to more pain? Do you feel that taking part in the study has exposed you to risk of physical harm?
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Short Physical Performance Battery (SPPB)
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed via activpal, mean minutes per day
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed via activpal, mean minutes per day
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed via activpal, mean minutes per day
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed via activpal, n/day
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Assessed via activpal, n/day
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Measure of Older Adults' Sedentary Time (MOST)
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
EuroQol five dimensions questionnaire (EQ-5D) Assessed for each subscale (1-5 score on each); Mobility, Self-Care, Usual Activities, Pain, and Anxiety
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Scale of overall perceived health on that day: scale 1-100 (100 is best, 0 is worst)
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Oxford Hip/Knee Score. Reported as a scale from 0-48, where 0 is the most severe hip/knee osteoarthritis, and 48 is no indication of hip/knee osteoarthritis.
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
Three subscales: autonomy, relatedness, and competence. R equals reverse scoring. Max score for each is 49. Total score is not computed.
Autonomy:
1, 4(R), 8, 11(R), 14, 17, 20(R)
Competence:
3(R), 5, 10, 13, 15(R), 19(R)
Relatedness:
2, 6, 7(R), 9, 12, 16(R), 18(R), 21
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
The International Physical Activity Questionnaire (IPAQ) Short Form asks the amount of hours spent doing vigorous, moderate, and walking activities per day, and for how many days. It also asks for the average perceived sitting time per day.This gives a score for self-reported Vigorous Physical Activity, Moderate Physical Activity, Walking, and Sitting time.
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Each item assess independence, in several domains, namely has a maximal overall score of 6 indicating maximal independence. The items are Bathing, Dressing, Toileting, Continence, Transferring (from bed to chair) and Feeding.
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)
KGs
Time frame: Baseline (visit 1, week 1)
CMs
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
kg/m2
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Waist to Hip Ratio (WHR) = Gw / Gh
Time frame: Baseline (visit 1, week 1)
Short Form Mini Nutritional Assessment (SF-MNA). Gives a scale from 0-14, where 0 is most severely malnourished.
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Albumin
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
High Density Lipoprotein
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Low density lipoprotein
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Triglycerides
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Vitamin D
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
C-Reactive Protein
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Interleukin 6
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Tumor Necrosis Factor Alpha
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Cortisol
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Dehydroepiandrosterone sulfate
Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)
Transferrin
University of Birmingham
Other
Intervention to Reduce Sedentary Time in Older Adults Undergoing Orthopaedic Surgery: a Feasibility Study (INTEREST)
Acronym: INTEREST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05381818
Arthropathy of Hip, Arthropathy of Knee
Jacksonville, Florida, United States
View Trial DetailsNCT06235710
Arthritis, Arthritis, Rheumatoid
Brunssum, Limburg, Netherlands
View Trial DetailsNCT06080412
Arthritis, Arthritis Shoulder
Boulogne-Billancourt, France
View Trial DetailsNCT05808959
Arthropathy of Hip, Behavior
Altındağ, Ankara, Turkey (Türkiye)
View Trial Details